Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Benjamin Larimer
Introduction
Benjamin Larimer is a notable inventor based in Woburn, MA (US). He has made significant contributions to the field of imaging and therapy through his innovative patents. With a total of 4 patents, Larimer's work focuses on advancing medical imaging techniques and therapeutic methods.
Latest Patents
One of Larimer's latest patents is centered around HER3 peptides for imaging and radiotherapy. This patent provides compositions useful for imaging HER3, featuring a structure that includes an imaging agent, a linking group, and a polypeptide. The compositions are designed to serve as radiotracers for position emission tomography (PET) imaging. Additionally, methods for imaging HER3 and combination therapies involving these imaging agents are included. Another significant patent involves granzyme B directed imaging and therapy. This patent outlines compounds that are useful for imaging granzyme B, also serving as radiotracers for PET and/or single photon emission tomography (SPECT) imaging. Methods for imaging granzyme B, combination therapies, and kits comprising the imaging agents are also detailed.
Career Highlights
Benjamin Larimer is associated with The General Hospital Corporation, where he applies his expertise in medical imaging and therapy. His work has contributed to advancements in the field, enhancing the capabilities of imaging technologies.
Collaborations
Larimer has collaborated with notable colleagues, including Umar Mahmood and Eric Wehrenberg-Klee. Their combined efforts have furthered the development of innovative imaging techniques and therapies.
Conclusion
Benjamin Larimer's contributions to the field of medical imaging and therapy through his patents demonstrate his commitment to innovation. His work continues to impact the medical community positively, paving the way for future advancements in imaging technologies.